These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2165363)
1. Distinction of NPY receptors in vitro and in vivo. II. Differential effects of NPY and NPY-(18-36). Scott NA; Michel MC; Boublik JH; Rivier JE; Motomura S; Crum RL; Landon M; Brown MR Am J Physiol; 1990 Jul; 259(1 Pt 2):H174-80. PubMed ID: 2165363 [TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. Grundemar L; Wahlestedt C; Reis DJ J Pharmacol Exp Ther; 1991 Aug; 258(2):633-8. PubMed ID: 1678015 [TBL] [Abstract][Full Text] [Related]
4. Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro. Michel MC; Schlicker E; Fink K; Boublik JH; Göthert M; Willette RN; Daly RN; Hieble JP; Rivier JE; Motulsky HJ Am J Physiol; 1990 Jul; 259(1 Pt 1):E131-9. PubMed ID: 2164786 [TBL] [Abstract][Full Text] [Related]
5. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA. Modin A; Malmström RE; Meister B Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500 [TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Zukowska-Grojec Z; Marks ES; Haass M Am J Physiol; 1987 Nov; 253(5 Pt 2):H1234-9. PubMed ID: 3688263 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats. Aubert JF; Walker P; Grouzmann E; Nussberger J; Brunner HR; Waeber B Clin Exp Pharmacol Physiol; 1992 Apr; 19(4):223-8. PubMed ID: 1325309 [TBL] [Abstract][Full Text] [Related]
8. Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels. Aubert JF; Burnier M; Waeber B; Nussberger J; Dipette DJ; Burris JF; Brunner HR J Pharmacol Exp Ther; 1988 Mar; 244(3):1109-15. PubMed ID: 3075238 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Kalra SP; Fuentes M; Fournier A; Parker SL; Crowley WR Endocrinology; 1992 Jun; 130(6):3323-30. PubMed ID: 1317781 [TBL] [Abstract][Full Text] [Related]
10. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. McAuley MA; Westfall TC J Pharmacol Exp Ther; 1992 Jun; 261(3):863-8. PubMed ID: 1351098 [TBL] [Abstract][Full Text] [Related]
11. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors. Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766 [TBL] [Abstract][Full Text] [Related]
12. Dependence of hypotensive effect of neuropeptide-Y 18-36 fragment on intact vagus nerves. Potter EK; Persico M; Mitchell L; de Pietra MG; Loughnan M; Shine J; McCloskey DI J Auton Nerv Syst; 1992 Mar; 37(3):155-62. PubMed ID: 1587993 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes. Balasubramaniam A; Sheriff S J Biol Chem; 1990 Sep; 265(25):14724-7. PubMed ID: 2168390 [TBL] [Abstract][Full Text] [Related]
14. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226. Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of posterior hypothalamic injection of neuropeptide Y in awake rats. Martin JR; Knuepfer MM; Westfall TC Am J Physiol; 1991 Sep; 261(3 Pt 2):H814-24. PubMed ID: 1887927 [TBL] [Abstract][Full Text] [Related]
16. NPY Y(1) receptors are involved in cardio-respiratory responses to intravenous injection of neuropeptide Y in anaesthetized rats. Kaczyńska K; Szereda-Przestaszewska M Pharmacol Res; 2010 Nov; 62(5):444-9. PubMed ID: 20600918 [TBL] [Abstract][Full Text] [Related]
17. Exogenous NPY modulation of cardiac autonomic reflexes and its pressor effect in the conscious rabbit. Serone AP; Angus JA; Wright CE Br J Pharmacol; 1998 Apr; 123(7):1375-84. PubMed ID: 9579733 [TBL] [Abstract][Full Text] [Related]
18. Circulating neuropeptide Y in humans: relation to changes in catecholamine levels and changes in hemodynamics. Hauser GJ; Danchak MR; Colvin MP; Hopkins RA; Wocial B; Myers AK; Zukowska-Grojec Z Neuropeptides; 1996 Apr; 30(2):159-65. PubMed ID: 8771558 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and sympathetic effects of spinal administration of neuropeptide Y in rats. Chen XL; Knuepfer MM; Westfall TC Am J Physiol; 1990 Dec; 259(6 Pt 2):H1674-80. PubMed ID: 2260694 [TBL] [Abstract][Full Text] [Related]
20. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure. Callanan EY; Lee EW; Tilan JU; Winaver J; Haramati A; Mulroney SE; Zukowska Z Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1811-7. PubMed ID: 17804485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]